Literature DB >> 12692481

Methylphenidate facilitates and disinhibits the motor cortex in intact humans.

Tihomir V Ilić1, Alexei Korchounov, Ulf Ziemann.   

Abstract

Animal experiments show that motor recovery after focal brain injury is accelerated by the indirect norepinephrine agonist methylphenidate (MPH). The underlying mechanisms are unknown, but an MPH-induced increase in cortical excitability has been advocated. Here, we tested the acute effects of a single oral dose of 40 mg MPH (Ritalin) on motor cortical excitability in eight healthy subjects using focal transcranial magnetic stimulation. MPH increased the slope of the motor evoked potentials (MEP) intensity curve in a hand muscle, reduced short-interval intracortical inhibition, and increased I-wave facilitation. MEP threshold, cortical silent period and measures of spinal and neuromuscular excitability remained unaffected. Findings support the idea that MPH promotes accelerated motor recovery after lesion through facilitation and disinhibition.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12692481     DOI: 10.1097/00001756-200304150-00023

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  16 in total

1.  Effects of monoaminergic drugs on training-induced motor cortex plasticity in older adults.

Authors:  Trisha M Kesar; Samir R Belagaje; Paola Pergami; Marc W Haut; Gerald Hobbs; Cathrin M Buetefisch
Journal:  Brain Res       Date:  2017-06-17       Impact factor: 3.252

2.  Effects of lorazepam on short latency afferent inhibition and short latency intracortical inhibition in humans.

Authors:  V Di Lazzaro; A Oliviero; E Saturno; M Dileone; F Pilato; R Nardone; F Ranieri; G Musumeci; T Fiorilla; P Tonali
Journal:  J Physiol       Date:  2005-02-17       Impact factor: 5.182

Review 3.  Modulating Neural Circuits with Transcranial Magnetic Stimulation: Implications for Addiction Treatment Development.

Authors:  Colleen A Hanlon; Logan T Dowdle; J Scott Henderson
Journal:  Pharmacol Rev       Date:  2018-07       Impact factor: 25.468

4.  A combined therapeutic approach in stroke rehabilitation: A review on non-invasive brain stimulation plus pharmacotherapy.

Authors:  Carolina Perez; Leon Morales-Quezada; Felipe Fregni
Journal:  Int J Neurorehabil       Date:  2014-11-15

5.  Neuromodulatory neurotransmitters influence LTP-like plasticity in human cortex: a pharmaco-TMS study.

Authors:  Alexei Korchounov; Ulf Ziemann
Journal:  Neuropsychopharmacology       Date:  2011-05-04       Impact factor: 7.853

6.  Modulation of motorcortical excitability by methylphenidate in adult voluntary test persons performing a go/nogo task.

Authors:  Johannes Buchmann; A Dueck; W Gierow; H Zamorski; S Heinicke; H Heinrich; J Hoeppner; T Klauer; O Reis; F Haessler
Journal:  J Neural Transm (Vienna)       Date:  2009-12-10       Impact factor: 3.575

7.  Effects of acute doses of methylphenidate on inflammation and oxidative stress in isolated hippocampus and cerebral cortex of adult rats.

Authors:  Majid Motaghinejad; Manijeh Motevalian; Behnaz Shabab; Sulail Fatima
Journal:  J Neural Transm (Vienna)       Date:  2016-09-28       Impact factor: 3.575

8.  Atomoxetine treatment of ADHD in Tourette syndrome: reduction in motor cortex inhibition correlates with clinical improvement.

Authors:  Donald L Gilbert; Jie Zhang; Tara D Lipps; Nina Natarajan; Jared Brandyberry; Zhewu Wang; F Randy Sallee; Eric M Wassermann
Journal:  Clin Neurophysiol       Date:  2007-06-27       Impact factor: 3.708

Review 9.  Noninvasive Brain Stimulation in Pediatric Attention-Deficit Hyperactivity Disorder (ADHD): A Review.

Authors:  Belen Rubio; Aaron D Boes; Simon Laganiere; Alexander Rotenberg; Danique Jeurissen; Alvaro Pascual-Leone
Journal:  J Child Neurol       Date:  2015-12-10       Impact factor: 1.987

10.  Effects of methylphenidate on motor system excitability in a response inhibition task.

Authors:  Oliver Kratz; Martin S Diruf; Petra Studer; Wolfgang Gierow; Johannes Buchmann; Gunther H Moll; Hartmut Heinrich
Journal:  Behav Brain Funct       Date:  2009-02-27       Impact factor: 3.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.